Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Gender-Affirming Hair Removal Care for Transgender and Gender-Diverse Patients

Description

This talk reviewed gender-affirming hair removal for transgender and gender-diverse patients, emphasizing that care should be individualized and delivered within a multidisciplinary framework. Hair removal is often medically necessary, not cosmetic, particularly for transfeminine patients seeking facial/body hair reduction or preoperative preparation for vaginoplasty, and for transmasculine patients needing donor-site hair removal before phalloplasty. The speaker compared electrolysis and laser hair removal: electrolysis is the only FDA-approved permanent hair removal method and works for all hair and skin types, while laser hair removal is faster, less painful, better for larger areas, and most effective for light skin with dark hair, though it provides permanent hair reduction rather than complete removal. Studies were cited showing that access to hair removal is associated with improved depression, anxiety, and well-being, and that financial barriers and insurance denials are common. The speaker described a clinic workflow in New York using letters of medical necessity, insurance authorization, and CPT workarounds, noting that Medicaid and private coverage can be obtained when medical necessity is well documented. The talk also highlighted WPATH support for laser hair removal as evidence-based treatment, the impact of anti-trans legislation and insurance barriers, and the need for clinicians to create safe, affirming environments for patients seeking care.

View more

Conclusions

  • Hair removal is a medically necessary component of gender-affirming care for many transgender and gender-diverse patients, not merely a cosmetic service.
  • Laser hair removal is generally faster, less painful, and more effective for large areas than electrolysis, but electrolysis remains the only FDA-approved permanent option and works for all hair and skin types.
  • For transfeminine patients, hair removal helps with facial/body hair dysphoria and is also important before vaginoplasty to prevent hair-related complications in the neovagina.
  • For transmasculine patients, preoperative hair removal can be necessary at donor sites used for phalloplasty and neourethra creation.
  • Access to hair removal appears to improve mental health outcomes, including lower depression and anxiety, and may improve overall well-being.
  • Financial and insurance barriers are the dominant obstacles to receiving hair removal, making insurance coverage one of the most important interventions to expand access.
  • Most insurance policies still do not explicitly cover hair removal for transgender care, and reimbursement structures remain inconsistent or inadequate.
  • Clinical access can be improved through structured workflows, letters of medical necessity, and use of existing Medicaid or medical-necessity pathways.
  • Dermatologists can play a pivotal role in gender-affirming care by providing hair removal and other supportive skin-related treatments.
  • Current political and legal hostility toward transgender care increases barriers and makes it even more important for clinicians to create safe, evidence-based care environments.
  • Siringo NV, Berman ZP, Boczar D, et al. Techniques and trends of facial feminization surgery: a systematic review and representative case report. Ann Plast Surg. 2022;88(6):704-711.#10.1097/sap.0000000000002952
  • Hair removal and psychological well-being in transfeminine adults: associations with gender dysphoria and gender euphoria.#10.1080/09546634.2019.1687823
  • Thoreson N, Marks DH, Peebles JK, King DS, Dommasch E. JAMA Dermatology. 2020.
  • World Professional Association for Transgender Health (WPATH) Standards of Care.
  • AAD Position Statement on Sexual and Gender Diverse Health in Dermatology.